Aripiprazole improves olanzapine-associated obsessive compulsive symptoms in schizophrenia

Clinical Neuropharmacology

Volumn 34, Issue 6, 2011, Pages 256-257

  Schönfelder, Sandra ^a   Schirmbeck, Frederike ^a   Waltereit, Robert ^a   Englisch, Susanne ^a   Zink, Mathias ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

antipsychotics; aripiprazole; compulsive; obsessive; olanzapine; schizophrenia

Indexed keywords

ARIPIPRAZOLE; CLOMIPRAMINE; OLANZAPINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; TREATMENT RESPONSE;

BENZODIAZEPINES; FEMALE; HUMANS; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 82055194427     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31823429bd     Document Type: Article

References (22)

1. Schirmbeck F, Esslinger C, Rausch F, et al. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychol Med 2011;41(11):2361-2374.
2. Schirmbeck F, Zink M. Induces clozapine obsessive-compulsive symptoms in schizophrenia? A critical review of current evidence. Curr Neuropharmacol 2011. In press.
3. Lykouras L, Alevizos B, Michalopoulou P, et al. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:333-346. (Pubitemid 36403724)
4. Zink M, Knopf U, Kuwilsky A. Management of clozapine-induced obsessive compulsive symptoms in a man with schizophrenia. Austr NZ J Psychiatry 2006;41:293-294.
5. Rocha FL, Hara C. Benefits of combining aripiprazole to clozapine: three case reports. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1167-1169. (Pubitemid 43964840)
6. Chang JS, Ahn Y-M, Park HJ, et al. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2008;69:720-731. (Pubitemid 351838681)
7. Englisch S, Esslinger C, Inta D, et al. Clozapine-induced obsessive compulsive syndromes improve in combination with aripiprazole. Clin Neuropharmacol 2009;32:227-229.
8. Englisch S, Zink M. Combined antipsychotic treatment involving clozapine and aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1386-1392. (Pubitemid 352033663)
9. Sparshatt A, Taylor D, Patel MX, et al. A systematic review of aripiprazoleVdose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring. J Clin Psychiatry 2010;71:1447-1456.
10. Egashira N, Okuno R, Matsushita M, et al. Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms. Eur J Pharmacol 2008;592:103-108.
11. Bruins Slot LA, Bardin L, Auclair AL, et al. Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice. Behav Pharmacol 2008;19:145-152. (Pubitemid 351365692)
12. Bymaster FP, Rasmussen K, Calligaro DO, et al. In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. J Clin Psychiatry 1997;58(suppl 10):28-36. (Pubitemid 27333178)
13. Baptista T, Elfakih Y, Uzcategui E, et al. Pharmacological management of atypical antipsychotic-induced weight gain. CNS Drugs 2008; 22:477-495. (Pubitemid 351693690)
14. Smith E, Rothschild AJ, Heo M, et al. Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. Int Clin Psychopharmacol 2008;23:130-137. (Pubitemid 351535904)
15. Duggal HS. Aripirazole-olanzapine combination for treatment of schizophrenia. Can J Psychiatry 2004;49:151.
16. Wolf J, Fiedler U. Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole. J Clin Pharm Ther 2007;32:197-198. (Pubitemid 46449704)
17. Chen CH, Huang MC, Lu ML. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients. Clin Psychopharmacol 2007;27:516-517.
18. Englisch S, Weinbrenner A, Inta D, et al. Aripiprazole for the management of olanzapine-induced weight gain. Pharmacopsychiatry 2009;42:166-167.
19. Henderson DC, Fan X, Copeland PM, et al. Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. J Clin Psychopharmacol 2009;29:165-169.
20. Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008;65:28-37.
21. Newcomer JW, Campos JA, Marcus RN, et al. A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine. J Clin Psychiatry 2008;69:1046-1056. (Pubitemid 352031586)
22. Fleischhacker WW, McQuade RD, Marcus RN, et al. A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia. Biol Psychiatry 2009;65:510-517.